PlainRecalls
FDA Devices Moderate Class II Terminated

Hardy Diagnostics GBS Detect Cat no. A300. Used for the isolation and detection by enhanced hemolysis of gamma-hemolytic (non-hemolytic) Group B Streptococcus.

Reported: May 4, 2016 Initiated: March 21, 2016 #Z-1571-2016

Product Description

Hardy Diagnostics GBS Detect Cat no. A300. Used for the isolation and detection by enhanced hemolysis of gamma-hemolytic (non-hemolytic) Group B Streptococcus.

Reason for Recall

Performance failure; poor hemolytic reaction of non or weakly hemolytic group B streptococcus (GBS) with the target QC organism, Streptococcus agalactiae (ATCC 13813) due to product deterioration.

Details

Recalling Firm
Hardy Diagnostics
Units Affected
3,530 (353 pk/10)
Distribution
U.S. Distribution to the following states: AL, SC, FL, CT, VA, WI, MA, MI, WV, OH, IN, IL, NC, and TX.
Location
Santa Maria, CA

Frequently Asked Questions

What product was recalled?
Hardy Diagnostics GBS Detect Cat no. A300. Used for the isolation and detection by enhanced hemolysis of gamma-hemolytic (non-hemolytic) Group B Streptococcus.. Recalled by Hardy Diagnostics. Units affected: 3,530 (353 pk/10).
Why was this product recalled?
Performance failure; poor hemolytic reaction of non or weakly hemolytic group B streptococcus (GBS) with the target QC organism, Streptococcus agalactiae (ATCC 13813) due to product deterioration.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 4, 2016. Severity: Moderate. Recall number: Z-1571-2016.